These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16916987)

  • 21. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.
    Wong CS; Batchelor K; Bua J; Newall F
    Thromb Res; 2011 Oct; 128(4):331-4. PubMed ID: 21620442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
    Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
    Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Over-Anticoagulation in Warfarin Users in the UK General Population: A Nested Case-Control Study in a Primary Health Care Database.
    Martín-Pérez M; Gaist D; de Abajo FJ; García Rodríguez LA
    Thromb Haemost; 2019 Jan; 119(1):66-76. PubMed ID: 30597501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of home testing of international normalized ratio on clinical events.
    Matchar DB; Jacobson A; Dolor R; Edson R; Uyeda L; Phibbs CS; Vertrees JE; Shih MC; Holodniy M; Lavori P;
    N Engl J Med; 2010 Oct; 363(17):1608-20. PubMed ID: 20961244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
    Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
    Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Validation of R-T Estimation for CoaguChek XS INR Results.
    Richter C; Taylor J; Wright J; Fletcher B
    Ann Pharmacother; 2016 Aug; 50(8):645-8. PubMed ID: 27199494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-management of anticoagulation.
    Levi M
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):979-85. PubMed ID: 18666848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonadherence with INR monitoring and anticoagulant complications.
    Witt DM; Delate T; Clark NP; Garcia DA; Hylek EM; Ageno W; Dentali F; Crowther MA
    Thromb Res; 2013 Aug; 132(2):e124-30. PubMed ID: 23800635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
    Edwards HD; Webb RD; Conway SE
    Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
    Sandén P; Renlund H; Svensson PJ; Själander A
    Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life (QoL) and International Normalized Ratio (INR) control of patients attending anticoagulation clinics.
    Hasan SS; Teh KM; Ahmed SI; Chong DW; Ong HC; Naina B
    Public Health; 2015 Jul; 129(7):954-62. PubMed ID: 26138018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of anticoagulation control after heart valve surgery at the Kenyatta National Hospital, Nairobi.
    Ogendo SW
    East Afr Med J; 2000 Jul; 77(7):354-8. PubMed ID: 12862152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.